Kasturi Ganesh Barki1, Amitava Das1, Sriteja Dixith1, Piya Das Ghatak1, Shomita Mathew-Steiner1, Elizabeth Schwab1, Savita Khanna1, Daniel J Wozniak2, Sashwati Roy1, Chandan K Sen1. 1. The Ohio State University Comprehensive Wound Center, Center for Regenerative Medicine and Cell Based Therapies, Department of Surgery, Davis Heart and Lung Research Institute, The Ohio State University Wexner Medical Center, Columbus, OH. 2. The Ohio State University, Department of Microbial Infection and Immunity, Department of Microbiology, Center for Microbial Interface Biology, The Ohio State University, Columbus, OH.
Abstract
OBJECTIVE: This study was designed to employ electroceutical principles, as an alternative to pharmacological intervention, to manage wound biofilm infection. Mechanism of action of a United States Food and Drug Administration-cleared wireless electroceutical dressing (WED) was tested in an established porcine chronic wound polymicrobial biofilm infection model involving inoculation with Pseudomonas aeruginosa PAO1 and Acinetobacter baumannii 19606. BACKGROUND: Bacterial biofilms represent a major wound complication. Resistance of biofilm toward pharmacologic interventions calls for alternative therapeutic strategies. Weak electric field has anti-biofilm properties. We have previously reported the development of WED involving patterned deposition of Ag and Zn on fabric. When moistened, WED generates a weak electric field without any external power supply and can be used as any other disposable dressing. METHODS: WED dressing was applied within 2 hours of wound infection to test its ability to prevent biofilm formation. Alternatively, WED was applied after 7 days of infection to study disruption of established biofilm. Wounds were treated with placebo dressing or WED twice a week for 56 days. RESULTS: Scanning electron microscopy demonstrated that WED prevented and disrupted wound biofilm aggregates. WED accelerated functional wound closure by restoring skin barrier function. WED blunted biofilm-induced expression of (1) P. aeruginosa quorum sensing mvfR (pqsR), rhlR and lasR genes, and (2) miR-9 and silencing of E-cadherin. E-cadherin is critically required for skin barrier function. Furthermore, WED rescued against biofilm-induced persistent inflammation by circumventing nuclear factor kappa B activation and its downstream cytokine responses. CONCLUSION: This is the first pre-clinical porcine mechanistic study to recognize the potential of electroceuticals as an effective platform technology to combat wound biofilm infection.
OBJECTIVE: This study was designed to employ electroceutical principles, as an alternative to pharmacological intervention, to manage wound biofilm infection. Mechanism of action of a United States Food and Drug Administration-cleared wireless electroceutical dressing (WED) was tested in an established porcine chronic wound polymicrobial biofilm infection model involving inoculation with Pseudomonas aeruginosa PAO1 and Acinetobacter baumannii 19606. BACKGROUND:Bacterial biofilms represent a major wound complication. Resistance of biofilm toward pharmacologic interventions calls for alternative therapeutic strategies. Weak electric field has anti-biofilm properties. We have previously reported the development of WED involving patterned deposition of Ag and Zn on fabric. When moistened, WED generates a weak electric field without any external power supply and can be used as any other disposable dressing. METHODS:WED dressing was applied within 2 hours of wound infection to test its ability to prevent biofilm formation. Alternatively, WED was applied after 7 days of infection to study disruption of established biofilm. Wounds were treated with placebo dressing or WED twice a week for 56 days. RESULTS: Scanning electron microscopy demonstrated that WED prevented and disrupted wound biofilm aggregates. WED accelerated functional wound closure by restoring skin barrier function. WED blunted biofilm-induced expression of (1) P. aeruginosa quorum sensing mvfR (pqsR), rhlR and lasR genes, and (2) miR-9 and silencing of E-cadherin. E-cadherin is critically required for skin barrier function. Furthermore, WED rescued against biofilm-induced persistent inflammation by circumventing nuclear factor kappa B activation and its downstream cytokine responses. CONCLUSION: This is the first pre-clinical porcine mechanistic study to recognize the potential of electroceuticals as an effective platform technology to combat wound biofilm infection.
Authors: Dixie F Mollenkopf; Roger L Faubel; Preeti Pancholi; Timothy F Landers; Matthew M Erdman; Joshua B Daniels; Thomas E Wittum Journal: Antimicrob Agents Chemother Date: 2015-06-22 Impact factor: 5.191
Authors: Sashwati Roy; Darshan Patel; Savita Khanna; Gayle M Gordillo; Sabyasachi Biswas; Avner Friedman; Chandan K Sen Journal: Proc Natl Acad Sci U S A Date: 2007-08-29 Impact factor: 11.205
Authors: Jaideep Banerjee; Piya Das Ghatak; Sashwati Roy; Savita Khanna; Craig Hemann; Binbin Deng; Amitava Das; Jay L Zweier; Daniel Wozniak; Chandan K Sen Journal: PLoS One Date: 2015-03-24 Impact factor: 3.240
Authors: Priscilla L Phillips; Qingping Yang; Stephen Davis; Edith M Sampson; John I Azeke; Afifa Hamad; Gregory S Schultz Journal: Int Wound J Date: 2013-09-13 Impact factor: 3.315
Authors: Andrey Ethan Rubin; Osman Berk Usta; Rene Schloss; Martin Yarmush; Alexander Golberg Journal: Adv Wound Care (New Rochelle) Date: 2019-04-03 Impact factor: 4.730
Authors: Sashwati Roy; Shaurya Prakash; Shomita S Mathew-Steiner; Piya Das Ghatak; Varun Lochab; Travis H Jones; Prashanth Mohana Sundaram; Gayle M Gordillo; Vish V Subramaniam; Chandan K Sen Journal: Adv Wound Care (New Rochelle) Date: 2019-04-03 Impact factor: 4.730
Authors: Dolly K Khona; Sashwati Roy; Subhadip Ghatak; Kaixiang Huang; Gargi Jagdale; Lane A Baker; Chandan K Sen Journal: Bioelectrochemistry Date: 2021-08-04 Impact factor: 5.373
Authors: Xiaoju Zhou; Brooke A Brown; Amanda P Siegel; Mohamed S El Masry; Xuyao Zeng; Woran Song; Amitava Das; Puneet Khandelwal; Andrew Clark; Kanhaiya Singh; Poornachander R Guda; Mahadeo Gorain; Lava Timsina; Yi Xuan; Stephen C Jacobson; Milos V Novotny; Sashwati Roy; Mangilal Agarwal; Robert J Lee; Chandan K Sen; David E Clemmer; Subhadip Ghatak Journal: ACS Nano Date: 2020-09-25 Impact factor: 15.881
Authors: Chandan K Sen; Shomita S Mathew-Steiner; Amitava Das; Vishnu Baba Sundaresan; Sashwati Roy Journal: Antioxid Redox Signal Date: 2020-07-10 Impact factor: 8.401
Authors: Maximillian A Weigelt; Stephanie A McNamara; Daniela Sanchez; Penelope A Hirt; Robert S Kirsner Journal: Adv Wound Care (New Rochelle) Date: 2020-06-22 Impact factor: 4.730
Authors: Maximillian A Weigelt; Hadar A Lev-Tov; Marjana Tomic-Canic; W David Lee; Ryan Williams; David Strasfeld; Robert S Kirsner; Ira M Herman Journal: Adv Wound Care (New Rochelle) Date: 2021-07-21 Impact factor: 4.730
Authors: Wen Yin; Siyang Xu; Yiting Wang; Yuling Zhang; Shan-Ho Chou; Michael Y Galperin; Jin He Journal: Crit Rev Microbiol Date: 2020-12-28 Impact factor: 7.624